Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT00317148

Effect of Dehydroepiandrosterone (DHEA) on Hot Flashes in Postmenopausal Women

Phase II-III Placebo-Controlled, Study to Evaluate the Effects of DHEA on Vasomotor Symptoms (Hot Flashes) in Postmenopausal Women

Sponsor: CHU de Quebec-Universite Laval

Conditions Hot Flashes

Interventions DHEA capsule Placebos

Updated 7 times since 2017 Last updated: Apr 6, 2017 Started: Aug 31, 2005 Primary completion: Sep 30, 2006 Completion: Dec 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2/PHASE3 trial investigates Hot Flashes and is currently completed. CHU de Quebec-Universite Laval leads this study, which shows 7 recorded versions since 2005 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2_PHASE3
Jul 2017 — Jun 2018 [monthly]

Completed PHASE2_PHASE3

▶ Show 2 earlier versions

May 2017 — Jul 2017 [monthly]

Completed PHASE2_PHASE3

Status: Unknown Status → Completed
Jan 2017 — May 2017 [monthly]

Unknown Status PHASE2_PHASE3

First recorded

Aug 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

CHU de Quebec-Universite Laval

Data source: CHU de Quebec-Universite Laval

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Sainte-Foy, Canada